Charles Bennett to Drug-Related Side Effects and Adverse Reactions
This is a "connection" page, showing publications Charles Bennett has written about Drug-Related Side Effects and Adverse Reactions.
Connection Strength
5.593
-
Systemic Barriers and Potential Concerns from Reporting Serious Adverse Drug Reactions. Cancer Treat Res. 2022; 184:75-85.
Score: 0.678
-
Was There Something Rotten in Denmark: Nephrogenic System Fibrosis Cases Occurring in Copenhagen. Cancer Treat Res. 2022; 184:87-102.
Score: 0.678
-
Investigating Severe Adverse Reactions: Examples of the ANTICIPATE Methodology at Work. Cancer Treat Res. 2022; 184:129-140.
Score: 0.678
-
Consequences to Patients, Clinicians, and Manufacturers When Very Serious Adverse Drug Reactions Are Identified (1997-2019): A Qualitative Analysis from the Southern Network on Adverse Reactions (SONAR). Cancer Treat Res. 2022; 184:141-149.
Score: 0.678
-
Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions. Lancet Haematol. 2021 Aug; 8(8):e593-e604.
Score: 0.658
-
Toxicity and costs of toxicity associated with new cancer drugs: international implications. J Clin Oncol. 2014 Nov 10; 32(32):3591-2.
Score: 0.410
-
Linking drugs to obscure illnesses: lessons from pure red cell aplasia, nephrogenic systemic fibrosis, and Reye's syndrome. a report from the Southern Network on Adverse Reactions (SONAR). J Gen Intern Med. 2012 Dec; 27(12):1697-703.
Score: 0.350
-
Nighttime and weekend medication error rates in an inpatient pediatric population. Ann Pharmacother. 2010 Nov; 44(11):1739-46.
Score: 0.312
-
Adverse drug interactions: moving from perception to action. Pharmacoeconomics. 2010; 28(1):19-22.
Score: 0.295
-
Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant. 2007 Aug; 40(3):185-92.
Score: 0.247
-
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Arch Intern Med. 2007 May 28; 167(10):1041-9.
Score: 0.246
-
Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication. Expert Opin Drug Saf. 2011 Jul; 10(4):521-8.
Score: 0.081
-
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood. 2009 May 14; 113(20):4834-40.
Score: 0.070
-
Epoetin-associated pure red cell aplasia: past, present, and future considerations. Transfusion. 2008 Aug; 48(8):1754-62.
Score: 0.066
-
Adverse effects of drugs used to treat hematologic malignancies: surveillance efforts from the research on adverse drug events and reports project. Semin Thromb Hemost. 2007 Jun; 33(4):365-72.
Score: 0.062
-
High rates of adverse drug events in a highly computerized hospital. Arch Intern Med. 2005 May 23; 165(10):1111-6.
Score: 0.054
-
Evaluation of a potential clinical interaction between ceftriaxone and calcium. Antimicrob Agents Chemother. 2010 Apr; 54(4):1534-40.
Score: 0.018
-
Low literacy impairs comprehension of prescription drug warning labels. J Gen Intern Med. 2006 Aug; 21(8):847-51.
Score: 0.015